Stock listing

KRX:128940 Hanmi Pharmaceutical Co., Ltd. (한미약품) 주가

Follow Hanmi Pharmaceutical Co., Ltd. into a list and get an email when it puts out news.

Share price · KRX:128940

₩415,000 KRW +26,500 (+6.8%)

Close on Oct 30, 2026

Past year +6.3% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
₩397,000 – ₩421,500 KRWOct 30, 2026
Volume
248,559 sharesOct 30, 2026
Market cap
₩5.27T KRWAt the close on Oct 30, 2026 · price × 12.69M shares outstanding
52-week range
₩302,000 – ₩647,000 KRWLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
₩62.04B KRWMedian day 97,394 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Hanmi Pharmaceutical Co., Ltd. logo

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · KRX:128940 · KRW, adjusted for splits

DayCloseChange%OpenHighLowVolume
₩415,000+26,500+6.8%₩410,000₩421,500₩397,000248,559
₩388,500+19,000+5.1%₩390,500₩393,000₩375,500156,029
₩369,500+19,000+5.4%₩355,000₩387,500₩355,000112,716
₩350,500-2,000-0.6%₩353,000₩359,500₩346,50072,298
₩352,500-9,000-2.5%₩353,000₩365,500₩350,00066,811
₩361,500-9,000-2.4%₩366,000₩370,500₩355,50058,384
₩370,500-9,000-2.4%₩378,000₩388,500₩368,00074,228
₩379,500+1,000+0.3%₩383,000₩393,500₩376,50071,552
₩378,500-11,000-2.8%₩389,000₩396,500₩373,00053,807
₩389,500-8,000-2.0%₩389,500₩394,500₩370,000102,740
₩397,500+11,500+3.0%₩390,500₩407,500₩386,50083,957
₩386,000-18,500-4.6%₩390,500₩393,500₩370,000204,667
₩404,500-48,500-10.7%₩444,000₩447,500₩394,500254,219
₩453,000-21,500-4.5%₩460,000₩470,000₩444,000112,625
₩474,500-6,000-1.2%₩482,000₩488,000₩467,00092,716
₩480,500-53,500-10.0%₩526,000₩526,000₩475,000274,223
₩534,000+11,000+2.1%₩538,000₩551,000₩516,000191,955
₩523,000+17,000+3.4%₩505,000₩527,000₩498,00093,800
₩506,000+8,500+1.7%₩501,000₩507,000₩492,50055,128
₩497,500-1,500-0.3%₩498,000₩526,000₩493,50091,908
₩499,000-8,000-1.6%₩500,000₩517,000₩486,00071,699
₩507,000+3,000+0.6%₩503,000₩514,000₩490,00064,128
₩504,000-16,000-3.1%₩520,000₩521,000₩498,50073,375
₩520,000+18,000+3.6%₩506,000₩534,000₩506,000126,975
₩502,000-3,000-0.6%₩505,000₩508,000₩498,50057,667
₩505,000+2,000+0.4%₩507,000₩512,000₩500,00040,448
₩503,000-12,000-2.3%₩511,000₩519,000₩500,000103,885
₩515,000+13,000+2.6%₩507,000₩528,000₩501,000175,609
₩502,000+5,500+1.1%₩503,000₩514,000₩495,000152,533
₩496,500+22,500+4.7%₩479,000₩507,000₩477,500178,299
₩474,000+10,000+2.2%₩454,000₩485,000₩452,000130,957
₩464,000-17,500-3.6%₩467,000₩472,500₩458,00064,512
₩481,500-13,000-2.6%₩488,000₩490,500₩475,000130,632
₩494,500+23,500+5.0%₩465,000₩495,500₩461,500136,830
₩471,000-4,500-0.9%₩480,000₩485,000₩466,00099,415
₩475,500+2,000+0.4%₩470,500₩475,500₩457,00096,972
₩473,500+13,000+2.8%₩463,500₩486,500₩455,500151,326
₩460,500-13,500-2.8%₩475,500₩481,000₩451,000166,958
₩474,000-18,000-3.7%₩479,000₩509,000₩469,000194,645
₩492,000-500-0.1%₩489,000₩495,500₩478,00096,062
₩492,500-16,500-3.2%₩492,500₩500,000₩474,500153,116
₩509,000+5,000+1.0%₩507,000₩513,000₩494,000142,205
₩504,000-26,000-4.9%₩520,000₩533,000₩498,500209,506
₩530,000+29,000+5.8%₩527,000₩564,000₩514,000556,680
₩501,000-39,000-7.2%₩550,000₩553,000₩464,500711,201
₩540,000+124,500+30.0%₩438,000₩540,000₩438,000514,563
₩415,500+16,500+4.1%₩390,500₩428,000₩380,500124,032
₩399,000+10,500+2.7%₩403,000₩406,500₩384,00094,247
₩388,500-3,500-0.9%₩386,000₩394,000₩374,00049,525
₩392,000-6,500-1.6%₩395,500₩398,000₩385,50065,857
₩398,50000.0%₩395,000₩402,000₩389,75048,151
₩398,500+2,500+0.6%₩398,500₩400,500₩391,00079,772
₩396,000-17,000-4.1%₩412,000₩412,000₩392,50087,181
₩413,000+5,500+1.3%₩407,500₩430,000₩404,00057,185
₩407,500+15,000+3.8%₩390,500₩409,500₩389,50037,369
₩392,500+1,500+0.4%₩388,000₩393,500₩382,50052,649
₩391,000+11,000+2.9%₩381,500₩396,500₩378,50073,591
₩380,000+2,000+0.5%₩376,000₩388,000₩372,00097,816
₩378,000+32,500+9.4%₩341,000₩379,500₩340,50093,358
₩345,500+12,000+3.6%₩329,000₩355,000₩323,500101,994
₩333,500+22,000+7.1%₩313,500₩335,500₩312,000102,400
₩311,500-10,500-3.3%₩310,000₩329,000₩309,00078,126
Ticker
KRX:128940
Asset type
Stock
Exchange
KRX
Currency
KRW

What changed lately

Latest news

MegazoneCloud Begins Building Hanmi Pharmaceutical's Quality Assurance AI Agent with 'AIR Studio'

Sep 9, 2026

Closed ₩494,500 (+5.0%) on Sep 9, 2026

Aptose Biosciences Announces Results of Special Shareholders Meeting; Announces Receipt of Final Court Approval of Plan of Arrangement; Reports Year End 2025 Results and Corporate Highlights

Mar 31, 2026

Closed ₩553,000 (+7.4%) on Apr 1, 2026

Leading Independent Proxy Advisory Firm ISS Recommends Aptose Biosciences Shareholders Vote “FOR” Proposed Plan of Arrangement with Hanmi Pharmaceutical

Mar 19, 2026

Closed ₩560,000 (+7.9%) on Mar 20, 2026

Issued by another party

Rolvedon (Hanmi Pharm) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Mar 13, 2026

Closed ₩500,000 (+0.7%) on Mar 16, 2026

Aptose Biosciences Announces Amendment to Arrangement Agreement and Details of Postponed Special Meeting of Shareholders

Feb 24, 2026

Closed ₩591,000 (-4.1%) on Feb 25, 2026

Hanmi Secures Export Deal with Mexican Partner Sanfer for GLP-1 Obesity Drug and More

Jan 27, 2026

Closed ₩519,000 (+9.3%) on Jan 28, 2026

Aptose Biosciences Announces Rescheduling of Special Meeting of Shareholders to Approve the Acquisition by Hanmi Pending Final Clearance from SEC

Dec 19, 2025

Closed ₩438,000 (-0.7%) on Dec 22, 2025

Issued by another party

Aptose Biosciences Announces Arrangement Agreement for Acquisition by Hanmi Pharmaceutical

Nov 19, 2025

Closed ₩450,000 (-2.4%) on Nov 19, 2025

Hanmi's Oral Delivery Platform Compound Licensed to Gilead

Sep 29, 2025

Aptose and Hanmi Pharmaceutical Extend Loan Agreement to Continue Development of Tuspetinib in Triplet Therapy for AML

Sep 22, 2025

Issued by another party

All Hanmi Pharmaceutical Co., Ltd. news

Decks

Hanmi Pharmaceutical Co., Ltd. on 6ix

News releases
8 in the last 12 months · 14 in all · newest Sep 9, 2026 · oldest 2025
Decks
8 decks · latest 2022

Log in to ask 6ix AI your own questions about Hanmi Pharmaceutical Co., Ltd.